NCT00482586

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Outcomes Following Image-Guided Therapy for Hepatic Malignancies

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 137 (actual)
• Sponsor: Vanderbilt University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future. PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

Detailed description

OBJECTIVES: * Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies. OUTLINE: This is a pilot, prospective, longitudinal study. Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review. PROJECTED ACCRUAL: Not specified

Conditions

• Liver Cancer
• Metastatic Cancer

Interventions

Type	Name	Description
OTHER	medical chart review	Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.
OTHER	questionnaire administration	Patients with hepatic neoplasms who undergo Image-guided Therapy
PROCEDURE	quality-of-life assessment	Patients with hepatic neoplasms who undergo Image-guided Therapy

Timeline

• Start date: 2003-10-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2007-06-05
• Last updated: 2015-06-08

Locations

3 sites across 1 country: United States